Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
francesco.pontieri@uniroma1.it
Francesco Ernesto Pontieri
Professore Ordinario
Struttura:
DIPARTIMENTO DI NEUROSCIENZE, SALUTE MENTALE E ORGANI DI SENSO
E-mail:
francesco.pontieri@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
Preclinical and clinical study on type 3 metabotropic glutamate receptors in Parkinson's disease
NPJ PARKINSON'S DISEASE
2025
Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study
JMIR FORMATIVE RESEARCH
2025
The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson’s Disease
BRAIN SCIENCES
2024
Unveiling the Unpredictable in Parkinson’s Disease: Sensor-Based Monitoring of Dyskinesias and Freezing of Gait in Daily Life
BIOENGINEERING
2024
Metabotropic Glutamate Receptors Type 3 and 5 Feature the “NeuroTransmitter-type” of Glioblastoma: A Bioinformatic Approach
CURRENT NEUROPHARMACOLOGY
2024
Incidence and predictors of postural abnormalities in Parkinson’s disease: a PPMI cohort study
JOURNAL OF NEUROLOGY
2024
Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson’s disease: a systematic review
CLINICAL AUTONOMIC RESEARCH
2024
Age at Onset Influences Progression of Motor and Non-Motor Symptoms during the Early Stage of Parkinson’s Disease: A Monocentric Retrospective Study
BRAIN SCIENCES
2023
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel
PARKINSONISM & RELATED DISORDERS
2023
Turning When Using Smartphone in Persons With and Those Without Neurologic Conditions: Observational Study
JMIR. JOURNAL OF MEDICAL INTERNET RESEARCH
2023
Levodopa/carbidopa intestinal gel via percutaneous endoscopic transgastric jejunostomy in advanced Parkinson's disease: hitting two birds with one stone?
PARKINSONISM & RELATED DISORDERS
2023
Type-B monoamine oxidase inhibitors in neurological diseases: clinical applications based on preclinical findings
NEURAL REGENERATION RESEARCH
2023
Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
SENSORS
2023
The role of opicapone in the management of Parkinson's disease: an Italian consensus through a combined Nominal Group Technique and Delphi approach
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
2023
Cerebral hemodynamics and cognitive functions in the acute and subacute stage of mild ischemic stroke: a longitudinal pilot study
NEUROLOGICAL SCIENCES
2023
A surprising pattern of Sexual Dimorphism in the Eurasian otter (Lutra lutra) in Sweden
HYSTRIX
2023
Levodopa/carbidopa intestinal gel for pain related to levodopa-induced motor complications in Parkinson’s disease
NEUROLOGICAL SCIENCES
2022
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease
FRONTIERS IN NEUROLOGY
2022
Monoamine-Oxidase type B- Inhibitors and Cognitive Functions in Parkinson's Disease: Beyond the Primary Mechanism of Action
CURRENT NEUROPHARMACOLOGY
2022
Cognitive dual-task cost depends on the complexity of the cognitive task, but not on age and disease
FRONTIERS IN NEUROLOGY
2022
1
2
3
4
next >
last »
Progetti di Ricerca
Metabotropic glutamate receptors and L-DOPA-induced dyskinesia in Parkinson¿s disease: a preclinical and clinical study.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma